Literature DB >> 10807496

The potential role of the Arthus and Shwartzman reactions in the pathogenesis of pneumonic pasteurellosis.

R Ramírez-Romero1, K A Brogden.   

Abstract

Pneumonic pasteurellosis (PP) is an economically important disease in cattle, sheep, and goats. Pasteurella haemolytica is commonly isolated from the severe fibrinopurulent pneumonia that characterize this respiratory syndrome. During infection, the bacteria produce leukotoxin (LKT) and lipopolysaccharide (LPS), both potent inducers of inflammation. Nonetheless, it has also been demonstrated that an exacerbated host's inflammatory response is responsible for the severe lung damage. Despite research in this field, the pathogenesis of PP is still incomplete. Two classical models of acute inflammatory response induced in laboratory animals, the Arthus and Shwartzman reactions, could explain the pathogenesis of the severe lung lesions that characterize PP.

Entities:  

Mesh:

Year:  2000        PMID: 10807496     DOI: 10.1007/s000110050565

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  3 in total

1.  Increased anionic peptide distribution and intensity during progression and resolution of bacterial pneumonia.

Authors:  Amanda J Fales-Williams; Jack M Gallup; Rafael Ramírez-Romero; Kim A Brogden; Mark R Ackermann
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

Review 2.  Histopathological analogies in chronic pulmonary lesions between cattle and humans: basis for an alternative animal model.

Authors:  Rafael Ramírez-Romero; Alicia M Nevárez-Garza; Luis E Rodríguez-Tovar; Alfredo Wong-González; Rogelio A Ledezma-Torres; Gustavo Hernández-Vidal
Journal:  ScientificWorldJournal       Date:  2012-05-02

3.  Evolution of the leukotoxin promoter in genus Mannheimia.

Authors:  Jesper Larsen; Anders G Pedersen; Robert L Davies; Peter Kuhnert; Joachim Frey; Henrik Christensen; Magne Bisgaard; John E Olsen
Journal:  BMC Evol Biol       Date:  2009-05-29       Impact factor: 3.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.